|
US3891427A
(en)
*
|
1972-10-12 |
1975-06-24 |
Lectromelt Corp |
Method for melting prereduced ore and scrap
|
|
SE378735B
(Sortimente)
*
|
1972-11-17 |
1975-09-08 |
Asea Ab |
|
|
FR2220584B1
(Sortimente)
*
|
1973-03-05 |
1976-05-21 |
Siderurgie Fse Inst Rech |
|
|
US3939297A
(en)
*
|
1973-12-07 |
1976-02-17 |
Chase Brass & Copper Co., Incorporated |
Stoker feed system
|
|
SE7503782L
(sv)
*
|
1975-04-02 |
1976-10-03 |
Asea Ab |
Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
|
|
DE2632707C3
(de)
*
|
1976-07-21 |
1983-04-07 |
Ernst Dipl.-Ing. 4006 Erkrath Beiersdorf |
Beschickungsanlage an Elektro-Lichtbogenöfen zur Zugabe von Legierungsmitteln und Zuschlagstoffen
|
|
US4133967A
(en)
*
|
1977-06-24 |
1979-01-09 |
The United States Of America As Represented By The Secretary Of The Interior |
Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
|
|
US4447906A
(en)
*
|
1981-02-02 |
1984-05-08 |
Lectromelt Corporation |
Arc furnace for producing aluminum
|
|
SE8303372L
(sv)
*
|
1983-06-14 |
1984-12-15 |
Asea Ab |
Ugnsanordning for smeltning av metaller eller metallegeringar
|
|
AT384669B
(de)
*
|
1986-03-17 |
1987-12-28 |
Voest Alpine Ag |
Anlage zur herstellung von stahl aus schrott
|
|
CA1311787C
(en)
*
|
1986-06-24 |
1992-12-22 |
Masahisa Tate |
Method of bottom blowing operation of a steel making electric furnace
|
|
FR2705767B1
(fr)
*
|
1993-05-27 |
1995-07-21 |
Lorraine Laminage |
Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
|
|
DE4339226A1
(de)
*
|
1993-11-15 |
1995-05-18 |
Mannesmann Ag |
Verfahren und Vorrichtung zur Wertstoffgewinnung
|
|
LU88517A7
(fr)
*
|
1993-12-15 |
1996-02-01 |
Wurth Paul Sa |
Dispositif de chargement d'un four électrique
|
|
AT404841B
(de)
|
1995-04-10 |
1999-03-25 |
Voest Alpine Ind Anlagen |
Anlage und verfahren zum herstellen von eisenschmelzen
|
|
US6673827B1
(en)
|
1999-06-29 |
2004-01-06 |
The Uab Research Foundation |
Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
|
|
US7227011B2
(en)
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
|
WO2000070285A1
(en)
*
|
1999-05-18 |
2000-11-23 |
Danieli Technology, Inc. |
Electric arc furnace for continuous charging
|
|
EP1702983A3
(en)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
|
|
AU2001278875B2
(en)
*
|
2000-07-06 |
2007-06-07 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tetrahydrobenzothiazole analogues as neuroprotective agents
|
|
AU2001276957A1
(en)
*
|
2000-07-17 |
2002-01-30 |
Advanced Research And Technology Institute |
Method of diagnosing pulmonary hypertension
|
|
AU9684601A
(en)
|
2000-10-12 |
2002-04-22 |
Univ Rochester |
Compositions that inhibit proliferation of cancer cells
|
|
US20040245317A1
(en)
*
|
2001-04-06 |
2004-12-09 |
Vladimir Larionov |
Artificial chromosomes that can shuttle between bacteria yeast and mammalian cells
|
|
US7320959B2
(en)
*
|
2001-10-01 |
2008-01-22 |
Vanderbilt University |
Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
|
|
AU2002332027A1
(en)
*
|
2001-10-04 |
2003-04-14 |
The Government Of The United States Of America, As |
Tandem repeat markers
|
|
EA010860B1
(ru)
|
2002-02-06 |
2008-12-30 |
Викор Текнолоджиз, Инк. |
Антиинфарктные молекулы
|
|
EP1552462B1
(en)
|
2002-06-14 |
2011-03-23 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Methods of treating and preventing colitis involving il-13 and nk-t cells
|
|
EP1575992A4
(en)
|
2002-08-05 |
2007-02-21 |
Univ Rochester |
CHEMICAL PROTEINS FROM PROTEIN TRANSDUCATING DOMAIN / DEAMINASE, RELATED COMPOUNDS AND THEIR USES
|
|
CA2505601C
(en)
|
2002-11-15 |
2014-10-28 |
Musc Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
|
EP2410332A1
(en)
|
2002-11-21 |
2012-01-25 |
The University Of Utah |
Method for identifying purinergic modulators of the olfactory system
|
|
CA2553745A1
(en)
|
2004-01-21 |
2005-08-04 |
University Of Utah Research Foundation |
Mutant sodium channel nav1.7 and methods related thereto
|
|
US8420096B2
(en)
|
2004-03-04 |
2013-04-16 |
Vanderbilt University |
Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling
|
|
WO2006016904A2
(en)
*
|
2004-04-14 |
2006-02-16 |
Uab Research Foundation |
Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock
|
|
US20050244335A1
(en)
*
|
2004-05-03 |
2005-11-03 |
Rinehart John J |
Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
|
|
WO2005110463A1
(en)
|
2004-05-11 |
2005-11-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health |
Methods of inhibiting proinflammatory cytokine expression using ghrelin
|
|
AU2005326817B2
(en)
|
2004-05-21 |
2012-04-19 |
Benaroya Research Institute |
Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
|
|
US20090118204A1
(en)
*
|
2004-11-18 |
2009-05-07 |
University Of Rochester |
Methods and Compositions Related to Esculentoside A
|
|
ES2620363T3
(es)
|
2004-12-21 |
2017-06-28 |
Musc Foundation For Research Development |
Composiciones y métodos para promover la cicatrización de heridas y la regeneración tisular
|
|
ES2412005T3
(es)
|
2005-04-15 |
2013-07-09 |
The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services |
Tratamiento y prevención de la enfermedad intestinal inflamatoria que implica IL-13 y células NKT
|
|
EP2371843B1
(en)
|
2005-05-19 |
2014-09-17 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services |
Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
|
|
US8859585B2
(en)
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
EP2447356B1
(en)
|
2005-06-07 |
2016-04-20 |
DSM Nutritional Products AG |
Eukaryotic microorganisms for producing lipids and antioxidants
|
|
WO2007047512A2
(en)
|
2005-10-14 |
2007-04-26 |
Musc Foundation For Research Development |
Inhibition of pax2 by defb1 induction as a therapy for cancer
|
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
US8993719B2
(en)
|
2005-12-29 |
2015-03-31 |
The Regents Of The University Of California |
Methods and compositions related to mutant Kunitz domain I of TFPI-2
|
|
TWI515007B
(zh)
|
2006-01-05 |
2016-01-01 |
美國猶他大學研究基金會 |
改善以神經系統為標的之藥劑之性質之方法及組合物
|
|
US8815804B2
(en)
|
2006-02-06 |
2014-08-26 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to targeting tumors and wounds
|
|
CA2644952A1
(en)
*
|
2006-03-01 |
2007-09-13 |
The University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
US8470965B2
(en)
*
|
2006-03-01 |
2013-06-25 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
US8603751B2
(en)
|
2006-03-02 |
2013-12-10 |
The Uab Research Foundation |
Mycobacterial disease detection, treatment, and drug discovery
|
|
JP5484049B2
(ja)
|
2006-07-10 |
2014-05-07 |
シナプシン ファーマシューティカルズ， インコーポレイテッド |
神経学的障害を処置することおよび認知身体能力を強化することにおけるソレノプシンに関する組成物および方法ならびにその使用
|
|
EP2049564B1
(en)
|
2006-08-02 |
2017-05-17 |
The UAB Research Foundation |
Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
|
|
EP2066812A4
(en)
|
2006-09-21 |
2010-04-28 |
Univ Rochester |
COMPOSITIONS AND METHODS RELATED TO PROTEIN SHIFT THERAPY FOR MYOTONE DYSTROPHY
|
|
US8999317B2
(en)
|
2006-11-01 |
2015-04-07 |
University Of Rochester |
Methods and compositions related to the structure and function of APOBEC3G
|
|
BRPI0720038A2
(pt)
|
2006-12-11 |
2013-12-24 |
Univ Utah Res Found |
Métodos para inibir a permeabilidade vascular em tecido, para triar ou avaliar um agente que inibe a permeabilidade vascular, para tratar ou prevenir a síndrome da angústia respiratória, a retinopatia de prematuridade, a retinopatia diabética e a degeneração macular úmida em um indivíduo, para tratar indivíduos com sugestões repulsivas ou miméticos e para promover a angiogênese em um tecido, polipeptídeo isolado, ácido nucleico isolado, e, vetor
|
|
WO2008089440A2
(en)
|
2007-01-18 |
2008-07-24 |
University Of Utah Research Foundation |
Compositions and methods for detecting, treating, or preventing reductive stress
|
|
EP2596799B1
(en)
|
2007-02-08 |
2016-11-23 |
University of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
EP2139319A4
(en)
|
2007-03-22 |
2011-02-23 |
Univ Yale |
METHOD AND COMPOSITIONS FOR RIBOSWITCHES CONTROLLING THE ALTERNATIVE SPLICE
|
|
JP5671336B2
(ja)
|
2007-05-08 |
2015-02-18 |
バーナム インスティテュート フォー メディカル リサーチ |
組織非特異的アルカリホスファターゼ阻害因子および血管石灰化を処置するためのそれらの使用
|
|
WO2009023306A2
(en)
|
2007-05-09 |
2009-02-19 |
Burnham Institute For Medical Research |
Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
|
|
MX2009012676A
(es)
|
2007-05-23 |
2010-02-12 |
Uab Research Foundation |
Neuraminidasa neumococica no toxica y sus usos.
|
|
US20100286082A1
(en)
|
2007-05-29 |
2010-11-11 |
Yale University |
Riboswitches and methods and compositions for use of and with riboswitches
|
|
EP2166845B1
(en)
|
2007-06-21 |
2015-10-21 |
Musc Foundation for Research Development |
Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration
|
|
WO2009021163A2
(en)
*
|
2007-08-08 |
2009-02-12 |
University Of Rochester |
Enhancing gene transfer
|
|
TW200916113A
(en)
|
2007-08-08 |
2009-04-16 |
Sod Conseils Rech Applic |
Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
|
|
CA2696113A1
(en)
*
|
2007-08-10 |
2009-04-02 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
US8501912B2
(en)
|
2007-12-03 |
2013-08-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Filipil compositions and methods for treating cancer
|
|
US20090233993A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
|
WO2009137686A1
(en)
|
2008-05-08 |
2009-11-12 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
US8816095B2
(en)
*
|
2008-08-15 |
2014-08-26 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
US20100286762A1
(en)
*
|
2009-03-18 |
2010-11-11 |
Musc Foundation For Research Development |
Compositions and Methods for Ameliorating Clinical Electrical Disturbances
|
|
WO2010132665A1
(en)
|
2009-05-15 |
2010-11-18 |
Yale University |
Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
WO2011022502A1
(en)
|
2009-08-18 |
2011-02-24 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
WO2011031974A1
(en)
|
2009-09-10 |
2011-03-17 |
Southern Research Institute |
Acridine analogs in the treatment of gliomas
|
|
US20120321647A1
(en)
|
2010-01-12 |
2012-12-20 |
Yale University |
Structured rna motifs and compounds and methods for their use
|
|
US20130045181A1
(en)
|
2010-03-09 |
2013-02-21 |
Guangming Zhong |
Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease
|
|
EP2555802A1
(en)
|
2010-04-08 |
2013-02-13 |
Sanford-Burnham Medical Research Institute |
Methods and compositions for enhanced delivery of compounds
|
|
US20130143955A1
(en)
|
2010-08-09 |
2013-06-06 |
Yale University |
Cyclic di-GMP-II Riboswitches, Motifs, and Compounds, and Methods for Their Use
|
|
EP2651429B1
(en)
|
2010-12-15 |
2018-03-28 |
Neuroadjuvants, Inc. |
Neuropeptide analogs, compositions, and methods for treating pain
|
|
SG193500A1
(en)
|
2011-03-15 |
2013-10-30 |
Univ Utah Res Found |
Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
|
|
WO2012135385A1
(en)
|
2011-03-28 |
2012-10-04 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
WO2013036636A1
(en)
|
2011-09-06 |
2013-03-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods of treating cancer
|
|
EP3608401A1
(en)
|
2012-07-05 |
2020-02-12 |
Ohio State Innovation Foundation |
Compositions and methods related to viral vaccines
|
|
WO2014141111A1
(en)
|
2013-03-14 |
2014-09-18 |
Pluristem Ltd. |
Methods for prevention and treatment of graft-versus-host disease
|
|
WO2014201118A2
(en)
|
2013-06-11 |
2014-12-18 |
Sanford-Burnham Medical Research Institute |
Compositions and methods for targeted endometriosis treatment
|
|
PT3016512T
(pt)
|
2013-07-05 |
2020-02-24 |
H Lee Moffitt Cancer Ct & Res |
Cd33 solúvel para tratar síndromes mielodisplásicas (smd)
|
|
WO2015143335A1
(en)
|
2014-03-20 |
2015-09-24 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric coronavirus spike proteins
|
|
US10189878B2
(en)
|
2014-09-24 |
2019-01-29 |
University Of Utah Research Foundation |
Ebolavirus pre-hairpin intermediate mimics and methods of use
|
|
US10376549B2
(en)
|
2015-01-20 |
2019-08-13 |
Adcure Biotechnologies, Llc. |
Detargeted adenovirus variants and related methods
|
|
MX2017010698A
(es)
|
2015-02-20 |
2018-04-30 |
Univ Texas |
Metodos y composiciones para chlamydia atenuada como vacuna y vector.
|
|
US10765754B2
(en)
|
2015-08-28 |
2020-09-08 |
Navigen, Inc. |
Compositions and methods related to inhibition of respiratory syncytial virus entry
|
|
WO2017120549A1
(en)
|
2016-01-07 |
2017-07-13 |
Navigen, Inc. |
D-peptide inhibitors of hiv entry and methods of use
|
|
EA201892096A1
(ru)
|
2016-03-16 |
2019-08-30 |
Эйбоум Корпорейшн |
Нейтрализующие моноклональные антитела к il-25 и их применение
|
|
WO2017214197A1
(en)
|
2016-06-06 |
2017-12-14 |
University Of Central Florida Research Foundation, Inc. |
Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
|
|
AU2017301901B2
(en)
|
2016-07-29 |
2024-08-29 |
Ohio State Innovation Foundation |
Expression of pten-long with oncolytic viruses
|
|
KR20240042177A
(ko)
|
2016-10-05 |
2024-04-01 |
유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 |
Nk 세포 및 항-pdl1 암 요법과 관련된 방법 및 조성물
|
|
JP2020509021A
(ja)
|
2017-02-28 |
2020-03-26 |
ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド |
Ｎｋ細胞の骨髄ホーミングを改善するｐｍ２１粒子
|
|
EP3600343B1
(en)
|
2017-03-24 |
2022-11-23 |
Ohio State Innovation Foundation |
Novel recombinant adeno-associated viral vectors restricting off-target transduction in liver and uses thereof
|
|
WO2018183488A1
(en)
|
2017-03-28 |
2018-10-04 |
Ohio State Innovation Foundation |
Human pd1 peptide vaccines and uses thereof
|
|
WO2018196782A1
(en)
|
2017-04-27 |
2018-11-01 |
The University Of Hong Kong |
Use of hcn inhibitors for treatment of cancer
|
|
AU2018273963B2
(en)
|
2017-05-25 |
2023-07-20 |
University Of Central Florida Research Foundation, Inc. |
Novel oncolytic viruses for sensitizing tumor cells to killing by natural killer cells
|
|
WO2019067403A2
(en)
|
2017-09-26 |
2019-04-04 |
Sanford Burnham Prebys Medical Discovery Institute |
COMPOSITIONS AND METHODS FOR EVALUATION OF PAINFUL DEMYELINIZING AND NON-DEMYELING DISEASES
|
|
CN111479575B
(zh)
|
2017-12-13 |
2024-03-22 |
北卡罗莱纳州立大学 |
包含化疗剂和检查点抑制剂的组合物及使用方法
|
|
CN112135639B
(zh)
|
2018-04-06 |
2023-10-20 |
北卡罗莱纳州立大学 |
细胞组装介导的癌症免疫治疗检查点抑制剂的递送
|
|
EP3787655A4
(en)
|
2018-05-07 |
2022-08-10 |
Georgia State University Research Foundation Inc. |
Compositions and methods related to rhamnus prinoides (gesho) extract for the inhibition of polymicrobial biofilm formation
|
|
US20210228630A1
(en)
|
2018-05-16 |
2021-07-29 |
Research Institute At Nationwide Children's Hospital |
Generation of knock-out primary and expanded human nk cells using cas9 ribonucleoproteins
|
|
JP2021526556A
(ja)
|
2018-05-30 |
2021-10-07 |
ダイレクト バイオロジクス エルエルシー |
成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞（ｍｓｃ）の調製物を含む助剤、ならびにその使用方法
|
|
JP7579570B2
(ja)
|
2018-06-29 |
2024-11-08 |
ノース・キャロライナ・ステイト・ユニヴァーシティ |
術後治療用ｉｎ ｓｉｔｕ噴霧生体応答性免疫療法ゲル
|
|
WO2020051507A1
(en)
|
2018-09-06 |
2020-03-12 |
The Broad Institute, Inc. |
Nucleic acid assemblies for use in targeted delivery
|
|
US11331269B2
(en)
|
2018-09-06 |
2022-05-17 |
Massachusetts Institute Of Technology |
Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
|
|
US20220267435A1
(en)
|
2018-10-03 |
2022-08-25 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
|
|
WO2020092057A1
(en)
|
2018-10-30 |
2020-05-07 |
Yale University |
Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
|
|
EP3873505A4
(en)
|
2018-11-02 |
2022-08-10 |
The Johns Hopkins University |
ADENOVIRAL CHIMERA TDP-43 PROTEINS
|
|
US20220136064A1
(en)
|
2019-02-09 |
2022-05-05 |
King Abdullah University Of Science And Technology |
Compositions and methods for cancer diagnosis and prognosis
|
|
US11660330B2
(en)
|
2019-06-21 |
2023-05-30 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy
|
|
US12213995B2
(en)
|
2019-07-18 |
2025-02-04 |
Direct Biologics, Llc |
Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
|
|
IL297335A
(en)
|
2020-04-14 |
2022-12-01 |
Univ California |
Corona virus vaccine compounds
|
|
US11225508B1
(en)
|
2020-09-23 |
2022-01-18 |
The University Of North Carolina At Chapel Hill |
Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
|
|
JP2023554589A
(ja)
|
2020-11-27 |
2023-12-28 |
ジェネラル ナノセラピューティクス エルエルシー |
免疫媒介性疾患の治療のための方法及び組成物
|
|
US20230279442A1
(en)
|
2021-12-15 |
2023-09-07 |
Versitech Limited |
Engineered cas9-nucleases and method of use thereof
|
|
KR102436232B1
(ko)
*
|
2022-01-17 |
2022-08-25 |
주식회사 세명하이트 |
원통형 필터 제조방법 및 이에 따라 제조된 원통형 필터
|
|
US20250228940A1
(en)
|
2022-03-11 |
2025-07-17 |
Yale University |
Compositions and methods for efficient and stable genetic modification of eukaryotic cells
|
|
US20250161360A1
(en)
|
2022-05-10 |
2025-05-22 |
Yale University |
Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
|
|
KR102736561B1
(ko)
*
|
2022-06-03 |
2024-12-02 |
현대제철 주식회사 |
전기로
|
|
KR102751454B1
(ko)
*
|
2022-06-03 |
2025-01-10 |
현대제철 주식회사 |
전기로
|
|
KR102829902B1
(ko)
*
|
2022-07-29 |
2025-07-04 |
현대제철 주식회사 |
전기로
|
|
KR102777625B1
(ko)
*
|
2022-07-29 |
2025-03-11 |
현대제철 주식회사 |
전기로
|
|
KR102793154B1
(ko)
*
|
2022-08-26 |
2025-04-07 |
현대제철 주식회사 |
전기로
|
|
KR102752443B1
(ko)
*
|
2022-08-26 |
2025-01-09 |
현대제철 주식회사 |
전기로
|
|
WO2024064824A2
(en)
|
2022-09-21 |
2024-03-28 |
Yale University |
Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
|
|
WO2024102997A1
(en)
|
2022-11-11 |
2024-05-16 |
Peterson Jeff R |
Gout flare prevention methods using il-1β inhibitors
|
|
KR102799788B1
(ko)
*
|
2022-11-29 |
2025-04-22 |
현대제철 주식회사 |
전기로용 저취교반장치 및 이를 포함하는 전기로
|
|
WO2024155821A1
(en)
|
2023-01-18 |
2024-07-25 |
Yale University |
Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
|
|
WO2024226829A2
(en)
|
2023-04-26 |
2024-10-31 |
Yale University |
Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer
|
|
WO2024238656A1
(en)
|
2023-05-15 |
2024-11-21 |
Yale Univeristy |
Chimeric antigen receptor compositions, car-mast cells formed therefrom, and methods of use thereof
|
|
US12269875B2
(en)
|
2023-08-03 |
2025-04-08 |
Jeff R. Peterson |
Gout flare prevention methods using IL-1BETA blockers
|
|
WO2025158400A1
(en)
|
2024-01-24 |
2025-07-31 |
Yale University |
Compositions and methods of natural killer cell hyperboosts for enhancement of nk cell therapy
|